Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Journal of Clinical Immunology|August 29, 2023
Severe RAS-Associated Lymphoproliferative Disease Case with Increasing αβ Double-Negative T Cells with Atypical FeaturesDaisuke Kurita, Norio Shiba, Takashi Ohya, et al.
International Journal of Hematology|February 1, 2025
Establishment of a high-risk pediatric AML-derived cell line YCU-AML2 with genetic and metabolic vulnerabilitiesJunji Ikeda, Norio Shiba, Shota Kato, et al.
Pediatric Blood & Cancer|September 29, 2020
The outcomes of relapsed acute myeloid leukemia in children: Results from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05R studyHiroshi Moritake, Shiro Tanaka, Takako Miyamura, et al.
Pediatric Blood & Cancer|October 2, 2018
Comparison of conditioning regimens for autologous stem cell transplantation in children with acute myeloid leukemia: A nationwide retrospective study in JapanHirotoshi Sakaguchi, Hideki Muramatsu, Daiichiro Hasegawa, et al.
British Journal of Haematology|February 21, 2019
Clinical and biological features of paediatric acute myeloid leukaemia (AML) with primary induction failure in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 studyTakako Miyamura, Hiroshi Moritake, Hideki Nakayama, et al.
British Journal of Haematology|October 16, 2019
Patients aged less than 3 years with acute myeloid leukaemia characterize a molecularly and clinically distinct subgroupYusuke Hara, Norio Shiba, Genki Yamato, et al.
Genes, Chromosomes & Cancer|May 1, 2013
NUP98-NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemiaNorio Shiba, Hitoshi Ichikawa, Tomohiko Taki, et al.
British Journal of Haematology|December 20, 2015
High PRDM16 expression identifies a prognostic subgroup of pediatric acute myeloid leukaemia correlated to FLT3-ITD, KMT2A-PTD, and NUP98-NSD1: the results of the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 trialNorio Shiba, Kentaro Ohki, Tohru Kobayashi, et al.
Pediatric Blood & Cancer|July 2, 2024
High DOCK1 expression identifies a distinct prognostic subgroup of pediatric acute myeloid leukemia: Results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trialMasahiro Yoshitomi, Shin-Ichi Tsujimoto, Junji Ikeda, et al.
British Journal of Haematology|February 3, 2026
Identification of cellular hierarchy in paediatric acute myeloid leukaemia: The Japan Children's Cancer Group trial (JCCG AML-12)Tomoya Komori, Tomoko Kawai, Yusuke Okuno, et al.
Pageof 6